Skip to content

H.R. 6094 · 118th Congress (2023–2025)

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.

Show official title

To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 6094’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Doris O. Matsui (D-CA-7)
Cosponsors
26 cosponsors

3 original · 23 later

8 R · 18 D

  1. Rep. Neal P. Dunn (R-FL-2)· Original · Oct 26, 2023
  2. Rep. Mike Kelly (R-PA-16)· Original · Oct 26, 2023
  3. Rep. Mike Thompson (D-CA-4)· Original · Oct 26, 2023
  4. Rep. Dean Phillips (D-MN-3)· Later · Nov 1, 2023
  5. Rep. Melanie A. Stansbury (D-NM-1)· Later · Jan 5, 2024
  6. Rep. Gus M. Bilirakis (R-FL-12)· Later · Jan 12, 2024
  7. Rep. Mikie Sherrill (D-NJ-11)· Later · Jan 17, 2024
  8. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Jan 29, 2024
  9. Del. Eleanor Holmes Norton (D-DC)· Later · Jan 29, 2024
  10. Rep. Steve Cohen (D-TN-9)· Later · Feb 5, 2024
  11. Rep. Don Bacon (R-NE-2)· Later · Feb 13, 2024
  12. Rep. Lizzie Fletcher (D-TX-7)· Later · Feb 14, 2024
  13. Rep. Donald G. Davis (D-NC-1)· Later · Feb 15, 2024
  14. Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Feb 28, 2024
  15. Rep. Lori Trahan (D-MA-3)· Later · Feb 28, 2024
  16. Rep. Shri Thanedar (D-MI-13)· Later · Feb 28, 2024
  17. Rep. Mike Quigley (D-IL-5)· Later · Feb 29, 2024
  18. Rep. Josh Gottheimer (D-NJ-5)· Later · Mar 5, 2024
  19. Rep. August Pfluger (R-TX-11)· Later · Mar 5, 2024
  20. Rep. Salud O. Carbajal (D-CA-24)· Later · Mar 6, 2024
  21. Rep. David J. Trone (D-MD-6)· Later · Mar 19, 2024
  22. Rep. Paul Tonko (D-NY-20)· Later · May 14, 2024
  23. Rep. Richard Hudson (R-NC-9)· Later · May 16, 2024
  24. Rep. Joe Neguse (D-CO-2)· Later · May 16, 2024
  25. Rep. Jake Auchincloss (D-MA-4)· Later · Sep 6, 2024
  26. Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Sep 16, 2024
Policy area
Health
Subjects
  • Health care costs and insurance
  • Health care coverage and access
  • Medicaid
  • Medicare
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 3 committee actions · Oct 26, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Oct 26, 2023
  2. HouseHealthReferred Nov 3, 2023
    1. Feb 29, 2024 · Hearing

  3. HouseWays and MeansReferred Oct 26, 2023
  4. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

    Display title, Short title · Introduced in House

  2. To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes.

    Official title · Introduced in House